Events
ESPMH organised/sponsored events
26th EUROPEAN CONFERENCE ON PHILOSOPHY OF MEDICINE AND HEALTH CARE
Worst Case BioethicsTue August 21, 2012 to Fri August 24, 2012
Other events
SATELLITE MEETING "Thinking ahead – The Future of the Declaration of Helsinki"
26. June, 2012 - 26. June, 20129 am – 4 pm, The Manhattan Hotel, Rotterdam
The Declaration of Helsinki is one of the most important international ethical regulations of biomedical research. It has been revised several times since its adoption in Helsinki in 1964. As a “living document”, it is continuously adapted to new developments and challenges in biomedical research. In 2011, the General Assembly of the World Medical Association decided to start a new process of revision. The WMA hence invites experts to share their views on the possible need for a revision of the Declaration of Helsinki at this satellite symposium. The WMA thereby wants to closely involve the bioethical science community in the ongoing discussion process of this upcoming revision.The conference organizers welcome submissions from different disciplines, including ethics/philosophy, theology, the social sciences, law, public health, medicine and others. We particularly encourage submissions from early career researchers. In their abstracts, applicants are encouraged to refer to certain paragraphs of the Declaration of Helsinki and to their respective wording in the 2008 version (revised in Seoul). Topics may include, but should not be limited to:
- The legal and ethical status of the Declaration of Helsinki
- The ethical basis of the Declaration
- The DoH in relation to other regulations of biomedical research
- Strengths and weaknesses of the DoH
- Challenges created by new methodological and scientific developments in biomedical research.
- Challenges created by social and political developments and the globalization of biomedical research.
The abstracts should not exceed 500 words. Presentations should be short and not exceed 10 min. Please send abstracts by February 1st 2012 to: Rotterdam2012@wma.net
Please note that the World Medical Association will not be in a position to provide travel costs for accepted speakers.
Participants and speakers are asked to register via the following email address: Rotterdam2012@wma.net
No fee will be charged. The number of participants is limited, early registration is recommended.
8th INTERNATIONAL CONFERENCE ON CLINICAL ETHICS AND CONSULTATION - Clinical Ethics and Diversity
16. May, 2012 - 19. May, 2012Calll for Abstracts
Holiday Inn Hotel– Anhembi – São Paulo, Brazil MAY 16‐19, 2012
We invite you to submit abstracts to the 8th International Conference on Clinical Ethics and Consultation.
The central theme of the conference is Clinical Ethics and Diversity. One core philosophical question is whether or not there is a sole canonical method for clinic ethics which might resolve ethical issues in every institutional scenario. Some believe that a method of universal human rights or even a method based on common morality will yield such a basis. Others recognize that there are multiple moral communities that provide normative moral foundations for health care decisions. Furthermore, the concrete and particular values within these communities are so complex and important that they should be taken into account. Beyond these broad questions, there are differences that emerge from law and custom as well as differences in the processes and procedures of health care institutions that make the provision of ethical advisory services more complex than it is commonly envisioned. The central theme of this conference, therefore, involves considering and understanding how these differences shape clinical ethics and to what extent do these differences affect the normative foundations of the field and its future development. Goals This conference aims to promote the development of the field of clinical ethics and clinical ethics advisory services internationally, as well as to foster, under an interdisciplinary focus, reflections and debates on a wide range of questions touching on the central topic. To do so, the conference will involve specialists and experienced professionals from several fields of knowledge in key roles. It is important that discussions and debates within the conference do not concentrate on the individual agendas of particular institutions or professional societies, but rather should aim for a broadening of perspectives on the field of clinical ethics and consultation, both in theoretical and practical spheres.
The 8th International Conference of Clinical Ethics and Consultation, in developing the central theme of Clinical Ethics and Diversity, thus requests that abstracts submitted offer contributions to this theme directly or in terms of nine large topics, listed below, upon which the approved abstracts will be grouped. The sub‐themes are:
1. Ethics Consultation and Ethical Decision Making in the Health Care
2. Cultural, Ethical, and Religious Diversity in Clinical Ethics
3. Education for Ethics Committees and Consultants
4. Matters of Care at the End of Life
5. Ethics Consultation and Ethics Committees
6. Influence of Cultural, Ethnic and Religious Commitments in Clinical Ethics Consultation
7. Methodology in Ethics Advisory / Counseling Services
8. Principles of Clinical Ethics and Consultation
9. Research on Ethics Consultation and Clinical Ethics
Please note: ‐ Accepted abstracts will only be placed on the program after the complete registration of the author(s) in the conference. ‐ The deadline for the reception of the abstracts is December 15th, 2011.
Abstracts should be submitted at the conference website: http://www.ethics2012.org.br
Information on the meeting, including registration, program, lodging, and other details will be regularly updated.
INTERNATIONAL EXPERT MEETING „Ethics in Oncology: New ethical issues“
11. May, 2012 - 12. May, 2012Target group:
Researchers and practioners in the fields of oncology, medical ethics, history of medicine, philosophy, psychology, theology, law, nursing and social work who have interdisciplinary research experience in the subject areas mentioned below.
Call for Papers
The advances in oncological therapy as well as the knowledge of the limitations to what is possible pose major ethical challenges for doctors, nurses and patients: The possibilities for treatment in oncology are expanding continuously. As a result patients are involved with increasingly complex treatment decisions, including end of life decisions. As a consequence doctors must inform their patients adequately, deliver difficult news and advise patients and their relatives on treatment goals and changes thereto, e.g. when changing from curative to palliative care.
One question which is always relevant in this context is what constitutes good doctor-patient communication. Due to new and in part complex possibilities to diagnose and treat tumors we have to consider which criteria are ethically relevant, i.e. which criteria should tip the scale when deciding on tumor-specific treatment (also in advanced stages of the illness), on therapies with marginal effectiveness or when dealing with patients in geriatric oncology.
Genetic testing of the tumor genome is fast becoming a common part of routine diagnosis and treatment planning. In future it is to be extended to the healthy genome. How can the information that was obtained coincidentally or intentionally be used responsibly?
Treatment often entails serious side effects, e.g. loss of fertility. In addition to the standard procedure of cryopreservation of sperm and embryos, research is currently being conducted on alternatives such as oocyte cryopreservation for single women or prepubertal girls. What is the risk-benefit analysis of this treatment and which ethical questions result from it?
Old patients are also confronted with specific questions and problems in oncological treatment. Physical as well as cognitive limitations are a particular challenge when communicating with the patient. Therapists have to be especially careful and thoughtful when supporting autonomous decision-making. Comorbidities and low functional reserves have a negative impact on patients’ quality of life, especially in the case of complex treatments with extensive side-effects.
At a societal level the question of a just allocation of resources arises: The proportion of cancer patients is on the rise because the population is ageing and new therapies enable cancer patients to live longer. On the other hand, these therapies are very cost-intensive and are said to have an “explosive effect” on our health care system which is solidarity-based. What price are we willing to pay for new therapies? Should these therapies be linked to effectiveness and what should a fair distribution look like?
These controversial issues in medical ethics are not only important for oncology but they are especially relevant in this field and have not been addressed in detail. This interdisciplinary conference with experts from a wide range of fields provides an opportunity to initiate and deepen the discussion of the above-mentioned issues.
Researchers and experts in the field of medicine are kindly invited to submit a 500-word abstract on the following topics by November 31, 2011 at the latest:
- Definition of treatment goals and communication,
- Personalised medicine: genetic diagnostics, biobanks and genome analyses,
- Financing new forms of treatment considering effectiveness and efficiency,
- Nursing and caregiving in oncology,
- Clinical cancer research: Opportunities, risks, perspectives,
- Vulnerable patient groups,
- Fertility preservation
Should you have further questions please contact Prof. Dr. Monika Bobbert (0049-(0)6221-54 5458) or Dr. Beate Herrmann (0049-(0)6221-56 37922); E-Mail: oncology-ethics@histmed.uni-heidelberg.de
Ist Conference of the International Association for Education in Ethics (IAEE)
1. May, 2012 - 3. May, 2012International Association for Education in Ethics (IAEE)
In April 2011 the International Association for Education in Ethics was officially established. At the initiative of UNESCO, a group of international scholars in ethics education created this global platform for exchange of experiences in the teaching of ethics. The Secretariat is established at the Center for Healthcare Ethics, Duquesne University, Pittsburgh, USA (www.duq.edu/chce).
Teaching ethics has a special significance at the global level and addresses a variety of different perspectives providing new insights into ethics from various cultural experiences from around the world. However, exchange of these experiences with education at the global level has been virtually non-existent. Thus, establishing a platform to promote education in ethics at a global scale is an exciting new initiative.
The goals of IAEE are to exchange and analyze experiences with the teaching of ethics in various educational settings, to promote the development of knowledge and methods of ethics education, to function as a global centre of contact for experts in this field, to promote contacts between members from countries around the world and to enhance and expand the teaching of ethics at national, regional and international levels.
The IAEE will be organizing international conferences and other scholarly meetings. The first international conference will take place at Duquesne University in Pittsburgh, USA, in May 2012. This conference will feature keynote lectures from experts and parallel sessions regarding a wide variety of fields. These fields of study include: bioethics, medical ethics, nursing ethics, pharmacy ethics, dental ethics, science ethics, engineering ethics, philosophical ethics, religious ethics and business ethics.
Those who are interested in becoming members of the International Association for Education in Ethics or would like to attend the first conference should visit the Center for Healthcare Ethics website at www.duq.edu/chce/iaee. For more information: contact Professor dr. Henk ten Have (tenhaveh@duq.edu).
Registration for membership: www.duq.edu/chce/iaee/register.cfm
Advanced European Bioethics Course “Human Genetics and Medical Technology”
12. March, 2012 - 15. March, 2012Nijmegen, the Netherlands
The department of IQ healthcare, Ethics, Philosophy and History of Medicine, Radboud University Nijmegen Medical Centre, announces the advanced European Bioethics Course ‘Human Genetics and Medical Technology’ from 12 -15 March 2012. During the course we will study the relation between technology and (medical) ethics. Focus of the course are the moral problems generated by the research and development and application of new knowledge in a range of emerging fields such as tissue engineering and genomics. Topics are, amongst others, screening and testing from clinical perspective, Health Technology Assessment, translational medicine and storage and analysis of (genetic) data. The key-note lecture will be held by Insoo Hyun PhD, Associate Professor in the Department of Bioethics and Director of the CWRU Stem Cell Ethics Center, Case Western Reserve University, Cleveland, USA.
This course is of interest to researchers working in the field of human genetics, biomedical sciences, life sciences, genetics and biology and physicians doing research that has a genetic component but also to professionals from other areas in healthcare such as physicians and nurses health care administrators, bioethics committee members, professionals working in the pharmaceutical industry, professionals in the areas of ethics, philosophy and theology, and PhD students undertaking courses of study in any of these areas.
Location: Radboud University Nijmegen Medical Centre, the Netherlands. Language: English. Price: Euro (€) 690 for early registration before January 16th, 2012, Euro (€) 790 for registration after this date. For more information, please consult our website: www.masterbioethics.org, under Intensive courses, Human Genetics and Medical Technology or contact Simone Naber: s.naber@iq.umcn.nl. Tel: [0031](0)24-3613359/[0031](0)24-3615320.
The intensive course Human Genetics and Medical Technology is part of the post-initial Erasmus Mundus Master of Bioethics program.
14th edition of the advanced European Bioethics Course - 'Suffering, Death and Palliative Care'
14. February, 2012 - 17. February, 2012The department IQ healthcare, section of Ethics, Philosophy and History of Medicine (Radboud University Medical Centre) organizes the 14th edition of the advanced European Bioethics Course ‘Suffering, death and palliative care’ from 14-17 February 2012. Aim of the course is to educate participants on a range of ethical issues related to suffering, palliative care and medically assisted death. Extensive insight into the medical, philosophical, theological and ethical foundations of these concepts will be proffered.
Location: Radboud University Nijmegen Medical Centre, the Netherlands. Language: English. Price: Euro (€) 690 for early registration before December 15th, 2011, Euro (€) 790 for registration after this date. For more information, please consult our website: www.masterbioethics.org,under Intensive courses or contact Simone Naber: s.naber@iq.umcn.nl. Tel: [0031](0)24-3613359/[0031](0)24-3615320.